Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00765362 · ClinicalTrials.gov registry record · Phase 3

Mobile - Bearing Knee Study

A Phase 3 study, sponsored by Encore Medical, L.P..

Completed
Registry status
Phase 3
Development phase
419
Enrollment target

NCT00765362: Completed Phase 3 study, sponsored by Encore Medical, L.P..

NCT00765362 is a Phase 3 study that has completed, run by Encore Medical, L.P.. The registered enrollment target is 419 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00765362, a Phase 3 study, has completed, sponsored by Encore Medical, L.P..

COMPLETED
Registry status
Phase 3
Development phase
419 participants
Enrollment target

Study Summary

To evaluate the safety and efficacy of the Encore Mobile-Bearing Knee.

Primary Outcome

The Knee Society Score includes a knee rating and function score. This evaluation covers the knee rating score with three main parameters of pain, stability and range of motion and that flexion contracture, extension lag and misalignment should be dealt with as deductions. Thus, 100 points will be obtained by a well-aligned knee with no pain, 125 degrees of motion, and negligible anteroposterior and mediolateral instability. 50 points are allotted for pain, 25 for stability, and 25 for range of

Interventions

  • DEVICE Encore Mobile-Bearing Knee

Trial Details

FieldValue
Enrollment Target 419 participants
Start Date 2000-01
Est. Completion 2008-08
Phase Phase 3
Encore Medical, L.P.

16 total trials

What the finished NCT00765362 record still lists

NCT00765362 is an interventional study that assigns participants to a tested intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (46% lower).

The record links to 0 conditions, and to 1 intervention - of which Encore Mobile-Bearing Knee is the first listed.

NCT00765362 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00765362 about?

NCT00765362 is a clinical study titled "Mobile - Bearing Knee Study". To evaluate the safety and efficacy of the Encore Mobile-Bearing Knee.

What is the current status of trial NCT00765362?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 419 participants. The study started on 2000-01. Estimated completion is 2008-08.

What interventions are being tested in trial NCT00765362?

The interventions under investigation include: Encore Mobile-Bearing Knee (DEVICE).

Who is sponsoring clinical trial NCT00765362?

This trial is sponsored by Encore Medical, L.P., which has 16 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00765362's enrollment target sits among peer trials

419 899th of 2000 higher than 1,101 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05579639 · 419 participants · Phase 2

    Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

  • NCT01790152 · 420 participants

    Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • NCT02701244 · 420 participants

    A Registry Study of Breast Microseed Treatment

  • NCT02966665 · 420 participants · Phase 1

    : Vascular Function in Health and Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00765362, the US trial registry maintained by the National Library of Medicine. NCT00765362 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.